InvestorsHub Logo
Followers 24
Posts 3145
Boards Moderated 0
Alias Born 07/30/2009

Re: manshoon1 post# 28967

Wednesday, 08/17/2011 9:37:04 AM

Wednesday, August 17, 2011 9:37:04 AM

Post# of 278644
RE: "just don't tell others what to do with their money explicitly"

I have never done that. I have given my opinion as to what I consider the likely result of certain actions which is something that almost all posters do here at times. What's more I have often very explicitly noted that what is best for any investor depends on their individual circumstances (something you have never done since I'be been here), which is in stark contrast to your contention.


RE: "Until revenues come in........then KBLB is valued on nothing."

There is nothing wrong with focusing your personal investment approach on revenues, EPS and other basic fundamentals appropriate and applicable to established companies with products.

However there are alternative methods that can be used to evaluate start up companies without products on the market and IMHO there is much to criticize in your repeated denial of that obvious reality and your inability/unwillingness to acknowledge it. KBLB has made a very remarkable achievement by succeeding in getting silkworms to produce a mixture of spider silk protein and worm silk protein. The market highly values such benchmarks and awards real value to them. Your persistent unwillingness to acknowledge that that achievement has value IMHO says far more about you than it does about the company.

Some of us are able to acknowledge the reality of other investment approaches even if we don't use them ourselves. I don't invest in established companies with products on the market and so do not use the methods of valuation you propound because they are completely inapplicable to startups with no products on the market and misapplication of them in the manner you propose leads to completely absurd results.

Intellectual property may be intangible and difficult to compute but that does not mean it does not have real value to the market. However one company paid $4.5 billion for Nortel's patent portfolio alone.

"None are so blind as those that will not see" source disputed
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KBLB News